Hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in apparently healthy Japanese individuals

被引:91
作者
Ishizaka, N
Ishizaka, Y
Toda, EI
Hashimoto, H
Nagai, R
Yamakado, M
机构
[1] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan
[2] Mitsui Mem Hosp, Ctr Multiphas Hlth Testing & Serv, Tokyo 101, Japan
[3] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan
关键词
metabolic syndrome; carotid artery; atherosclerosis; risk factor; cross-sectional study;
D O I
10.1291/hypres.28.27
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The cluster of metabolic and hemodynamic risk factors known as metabolic syndrome is known to be a risk factor for ischemic cardiovascular diseases and stroke. By analyzing the cross-sectional data from 8,144 individuals (age 19-88 years) who underwent general health screening, we have investigated the prevalence of metabolic syndrome, as diagnosed by modified-National Cholesterol Education Program (NCEP) criteria corresponding to the following five categories: triglycerides >= 150 mg/dl; high density lipoprotein (HDL)-cholesterol < 40 mg/dl in men or < 50 mg/dl in women; fasting plasma glucose >= 110 mg/dl; systolic/diastolic blood pressure >= 130/85 mmHg; and body mass index > 25 kg/m(2). We found that the prevalence of metabolic syndrome was 19% in men and 7% in women. After adjustment for age, metabolic syndrome was found to be significantly more prevalent in men than in women, with an odds ratio of 3.08 (95% confidence interval [CI] 2.62-3.61, p < 0.0001). Among the five metabolic/hemodynamic risk factor components, hypertension was observed most frequently in individuals with metabolic syndrome, at 85% in men and 87% in women. In addition, multivariate logistic regression analysis adjusted for age, sex, serum total cholesterol levels, and smoking status showed that hypertension possessed the greatest odds ratio (1.43, 95% CI 1.27-1.60) for carotid plaque among the metabolic/hemodynamic risk factors. These data emphasize the importance of controlling blood pressure for reducing the risk of both metabolic syndrome and carotid arteriosclerosis in apparently healthy individuals.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 26 条
[1]   Metabolic Syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Bonadonna, RC ;
Muggeo, M .
INTERNATIONAL JOURNAL OF OBESITY, 2003, 27 (10) :1283-1289
[2]   Carotid atherosclerosis and coronary heart disease in the metabolic syndrome - Prospective data from the Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2003, 26 (04) :1251-1257
[3]  
Chalmers J, 1999, J HYPERTENS, V17, P151
[4]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[5]   Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity [J].
Dobrian, AD ;
Schriver, SD ;
Khraibi, AA ;
Prewitt, RL .
HYPERTENSION, 2004, 43 (01) :48-56
[6]   Management of Co-existing diabetes mellitus and dyslipidemia: Defining the role of thiazolidinediones [J].
Florkowski C.M. .
American Journal of Cardiovascular Drugs, 2002, 2 (1) :15-21
[7]  
Fujishima M, 2001, HYPERTENS RES, V24, P613
[8]   Effect of the thiazolidinediones on cardiovascular risk factors [J].
Gilling L. ;
Suwattee P. ;
DeSouza C. ;
Asnani S. ;
Fonseca V. .
American Journal of Cardiovascular Drugs, 2002, 2 (3) :149-156
[9]   Echolucent carotid plaques predict future coronary events in patients with coronary artery disease [J].
Honda, O ;
Sugiyama, S ;
Kugiyama, K ;
Fukushima, H ;
Nakamura, S ;
Koide, S ;
Kojima, S ;
Hirai, N ;
Kawano, H ;
Soejima, H ;
Sakamoto, T ;
Yoshimura, M ;
Ogawa, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (07) :1177-1184
[10]   Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women [J].
Hu, G ;
Qiao, Q ;
Tuomilehto, J ;
Balkau, B ;
Borch-Johnsen, K ;
Pyorala, K .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (10) :1066-1076